CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 53,100 shares, a growth of 14.7% from the April 30th total of 46,300 shares. Currently, 0.8% of the shares of the company are […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Several other equities analysts also recently issued reports on ORIC. JPMorgan Chase & Co. reduced their price objective on ORIC Pharmaceuticals from $19.00 to $18.00 and set an […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 124,100 shares, a decrease of 18.9% from the April 30th total of 153,000 shares. Based on an average daily volume of 265,800 shares, […]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 1,400 shares, a decline of 30.0% from the April 30th total of 2,000 shares. Based on an average daily trading volume, of 29,400 shares, the short-interest […]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 1,400 shares, a drop of 30.0% from the April 30th total of 2,000 shares. Based on an average daily volume of 29,400 shares, the days-to-cover ratio […]